# Trinity League (NSE: TRINITYLEA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/TRINITYLEA · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹8 Cr, it ranks 3962nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Capital Markets.

Its return on equity was −5.8% in FY26. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹0 Cr (−30.8% year on year) and net profit ₹0 Cr (−61.9%), on a consolidated basis. Promoters held 61.01% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹8 Cr |
| ROE | −5.8% (FY26) |
| ROCE | −5.8% (FY26) |
| Debt to equity | 0 |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹0 Cr | −30.8% | ₹0 Cr | −61.9% | ₹0.10 |
| Q3 FY26 | — | — | −₹0 Cr | — | −₹0.07 |
| Q2 FY26 | — | — | −₹0 Cr | — | −₹0.03 |
| Q1 FY26 | — | — | −₹0 Cr | — | −₹0.10 |
| Q4 FY25 | ₹0 Cr | — | ₹0 Cr | — | ₹0.26 |
| Q3 FY25 | — | — | −₹0 Cr | −300.0% | −₹0.08 |
| Q2 FY25 | ₹0 Cr | — | −₹0 Cr | — | −₹0.06 |
| Q1 FY25 | — | — | −₹0 Cr | — | −₹0.51 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹0 Cr | −₹0 Cr |
| FY25 | ₹0 Cr | ₹0 Cr |
| FY24 | ₹0 Cr | −₹0 Cr |
| FY23 | ₹3 Cr | ₹0 Cr |
| FY22 | ₹2 Cr | ₹0 Cr |
| FY21 | ₹1 Cr | ₹0 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 61.01%
- Non-institutions: 38.99%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Broach Lifecare](https://app.pivotnow.in/stock/BROACH) | — | ₹9 Cr | — | — |
| [Clinitech Labor](https://app.pivotnow.in/stock/CTLLAB) | — | ₹9 Cr | — | — |
| [Genomic Valley](https://app.pivotnow.in/stock/GVBL) | — | ₹9 Cr | — | — |
| [Adline Chem Lab](https://app.pivotnow.in/stock/ADLINE) | — | ₹8 Cr | — | — |
| [Unjha Formula](https://app.pivotnow.in/stock/UNJHAFOR) | — | ₹8 Cr | — | — |
| [Dr Lalchandani](https://app.pivotnow.in/stock/DLCL) | — | ₹7 Cr | — | — |

## Questions and answers

### What is the market cap of Trinity League?

Trinity League's market capitalisation is ₹8 Cr (₹8 Cr) at the 22 Oct 2026 close, ranking 3962nd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Trinity League?

Return on equity was −5.8% in FY26 and return on capital employed was −5.8% in FY26 (consolidated figures).

### Is Trinity League a debt-free company?

Trinity League is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Trinity League's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Trinity League reported revenue of ₹0 Cr, −30.8% year on year, and net profit of ₹0 Cr, −61.9% year on year.

### What is the shareholding pattern of Trinity League?

As of 30 Jun 2026: promoters 61.01%, non-institutions 38.99%.

### Who are Trinity League's competitors?

The listed Pharma & Healthcare companies closest to Trinity League by market cap are Broach Lifecare, Clinitech Labor, Genomic Valley, Adline Chem Lab, Unjha Formula and Dr Lalchandani.

### Is Trinity League a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Trinity League's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on TRINITYLEA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.